Does Rallies show live market data for CLOV?

Rallies combines live market context with ticker research for CLOV, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.

CLOV (Clover Health Investments, Corp) Stock Analysis

Clover Health Investments, Corp (CLOV) is a publicly traded Healthcare sector company. As of May 21, 2026, CLOV trades at $3.57 with a market cap of $1.79B and a P/E ratio of 0.00. CLOV moved +2.57% today. Year to date, CLOV is +38.61%; over the trailing twelve months it is -2.71%. Its 52-week range spans $1.58 to $4.87. Analyst consensus is buy with an average price target of $2.98. Rallies surfaces CLOV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest CLOV stock research?

Clover Health Investments, Corp (CLOV) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CLOV moved +2.57% today. Analyst consensus is buy.

CLOV Key Metrics

Key financial metrics for CLOV
Metric	Value
Price	$3.57
Market Cap	$1.79B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$4.87
52-Week Low	$1.58
Volume	5.68M
Avg Volume	0
Revenue (TTM)	$2.21B
Net Income	$-56.94M
Gross Margin	0.00%

Latest CLOV News

Clover Health Posts $27M Q1 Profit, 62% Revenue Growth, 51% Membership Increase — May 6, 2026
CFO Change at Clover Health: Peter Kuipers Exits March 30, Thornton Named Interim, 2026 Guidance Reconfirmed — Apr 1, 2026
Medtech Surge Fuels Clover Health in $Billions Outpatient, AI Diagnostics Shift — Mar 27, 2026
Clover Health’s AI Assistant cuts flu events 22% and projects 49% revenue growth — Mar 19, 2026
Clover Health Launches Real-Time FHIR USCDI v3 Data Exchange on Kno2 — Mar 10, 2026

Recent CLOV Insider Trades

Priest Brady Patrick sold 98.04K (~$345.10K) on May 13, 2026.
Reynoso Jamie L. sold 5.83K (~$11.14K) on Mar 18, 2026.
Priest Brady Patrick sold 175.00K (~$379.75K) on Mar 4, 2026.

CLOV Analyst Consensus

2 analysts cover CLOV: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.98.

Common questions about CLOV

What can I research for CLOV on Rallies?: Clover Health Investments, Corp (CLOV) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CLOV moved +2.57% today. Analyst consensus is buy.
Does Rallies show live market data for CLOV?: Rallies combines live market context with ticker research for CLOV, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.